MyAmyloidosisTeam

That's wonderful news that your biomarkers show no cardiac involvement! While diflunisal isn't officially FDA-approved for amyloidosis, doctors often prescribe it "off-label" because it helps prevent amyloid formation. It's encouraging that you're responding well to the treatment. Wild-type amyloidosis typically develops Show Full Answer

That's wonderful news that your biomarkers show no cardiac involvement! While diflunisal isn't officially FDA-approved for amyloidosis, doctors often prescribe it "off-label" because it helps prevent amyloid formation. It's encouraging that you're responding well to the treatment. Wild-type amyloidosis typically develops slowly over time, which can lead to a more favorable prognosis compared to other types. With proper treatment and monitoring, many people with wild-type amyloidosis are living longer, healthier lives. Continue working closely with your healthcare team and maintaining regular biomarker checks to monitor your condition.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Wild-Type Amyloidosis (Senile Amyloidosis): Symptoms, Prognosis, and More

Life Expectancy With Amyloidosis: Prognosis for Different Types